Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC37639 Cyclam Featured
Cyclam (1,4,8,11-tetraazacyclotetradecane) is an organic compound. It is a white solid that is soluble in water. The compound is notable as a macrocyclic ligand, which binds strongly to many transition metal cations. The compound was first prepared by the reaction of 1,3-dibromopropane and ethylenediamine.
More description
DC36079 Artemisitene Featured
Artemisitene is an antimalarial agent and the oxidized form of Artemisinin. Artemisinin precursors are the important basic substances for biosynthesis of Artemisinin, including Artemisinic acid, Artemisinin B, Artemisitene, etc.
More description
DC20505 Pimozide Featured
Pimozide is an antipsychotic agent that acts as an antagonist of the D2, D3, and D4 receptors and the 5-HT7 receptor, also is an inhbitor of STAT5.
More description
DC9968 CCT251545 Featured
CCT251545 is an orally bioavailable and potent inhibitor of WNT signaling with IC50 value of 5 nM.
More description
DC45531 ICCB-19 hydrochloride Featured
ICCB-19 hydrochloride is an inhibitor of TNFRSF1A Associated Via Death Domain (TRADD) with IC50 of 1.12 μM and 2.01 μM for protecting Velcade-induced apoptosis in Jurkat cells and protecting RDA in MEFs, respectively. ICCB-19 indirectly inhibits Receptor-interacting serine/threonine-protein kinase 1 (RIPK1). ICCB-19 effectively induces autophagy.
More description
DC57060 Glucocorticoid receptor modulator-1 Featured
A novel Glucocorticoid receptor modulator.
More description
DC46699 9-Phenanthrol
9-Phenanthrol (9-Hydroxyphenanthrene, Phenanthren-9-o, 9-Phenanthrenol) is a selective TRPM4 inhibitor with an IC50 in the range of 0.02 μM, without effects on TRPM5.
More description
DC46697 Tertiapin-Q
Tertiapin-Q (TPNQ) is a derivative of tertiapin and inhibits BK-type K+ channels in a use- and concentration-dependent manner. Tertiapin-Q also binds to ROMK1 (Kir1.1) and GIRK1/4 (Kir3.1/3.4) channels with Ki values of 1.3 nM and 13.3 nM respectively.
More description
DC46696 RN-1747
RN-1747 is a selective TRPV4 agonist with EC50s of 0.77 μM, 4.0 μM and 4.1 μM for hTRPV4, mTRPV4 and rTRPV4, respectively. RN-1747 also antagonizes TRPM8 with IC50 of 4 μM.
More description
DC46692 NRD167
NRD167 is a potent and selective SIRT5 inhibitor.
More description
DC46688 Sevelamer-(d5)n hydrochloride
Sevelamer-(d5)n hydrochloride is the deuterium labeled Sevelamer hydrochloride. Sevelamer hydrochloride is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease; consists of polyallylamine that is crosslinked with epichlorohydrin.
More description
DC46687 Pomalidomide-PEG2-COOH
Pomalidomide-PEG2-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology.
More description
DC46685 Uridine triphosphate 13C9,15N2 sodium
Uridine triphosphate 13C9,15N2 (UTP 13C9,15N2) sodium is a labeled Uridine triphosphate sodium. Uridine triphosphate sodium can be used in nucleic acid synthesis.
More description
DC46684 Cytidine-5'-triphosphate
Cytidine 5′-triphosphate (5'-CTP) is a nucleoside triphosphate and serves as a building block for nucleotides and nucleic acids, lipid biosynthesis. Cytidine triphosphate synthase can catalyze the formation of cytidine 5′-triphosphate from uridine 5′-triphosphate (UTP). Cytidine 5′-triphosphate is an essential biomolecule in the de novo pyrimidine biosynthetic pathway in T. gondii.
More description
DC46683 5-O-TBDMS-N4-Benzoyl-2-deoxycytidine
5-O-TBDMS-N4-Benzoyl-2-deoxycytidine is a modified nucleoside. 5-O-TBDMS-N4-Benzoyl-2-deoxycytidine can be used in the synthesis of deoxyribonucleic acid or nucleic acid.
More description
DC46682 5'-O-TBDMS-dT
5'-O-TBDMS-dT is a nucleoside with protective and modification effects.
More description
DC46681 5'-O-TBDMS-dG
5'-O-TBDMS-dG is a modified nucleoside. 5'-O-DMT-2'-O-TBDMS-rI can be used in the synthesis of deoxyribonucleic acid or nucleic acid.
More description
DC46680 5'-O-TBDMS-dA
5'-O-TBDMS-dA is a modified nucleoside and can be used to synthesize DNA or RNA.
More description
DC46679 5'-O-TBDMS-Bz-dA
5'-O-TBDMS-Bz-dA is a nucleoside with protective and modification effects.
More description
DC46678 5'-O-DMT-rU
5'-O-DMT-rU is a modified nucleoside and can be used to synthesize RNA.
More description
DC46677 5'-O-DMT-rI
5'-O-DMT-Ri can be used in the synthesis of oligoribonucleotides.
More description
DC46676 5'-O-DMT-PAC-dA
5'-O-DMT-PAC-dA can be used in the synthesis of oligoribonucleotides.
More description
DC46675 5'-O-DMT-N4-Bz-5-Me-dC
5'-O-DMT-N4-Bz-5-Me-dC is a modified nucleoside. 5'-O-DMT-2'-O-TBDMS-rI can be used in the synthesis of deoxyribonucleic acid or nucleic acid.
More description
DC46674 5'-O-DMT-N4-Bz-2'-F-dC
5'-O-DMT-N4-Bz-2'-F-dC is a nucleoside with protective and modification effects.
More description
DC46673 5'-O-DMT-N4-Ac-2'-F-dC
5'-O-DMT-N4-Ac-2'-F-dC is a modified nucleoside and can be used to synthesize DNA or RNA.
More description
DC46672 5'-O-DMT-Bz-rC
5'-O-DMT-Bz-Rc is a modified nucleoside and can be used to synthesize DNA or RNA.
More description
DC46671 5'-O-DMT-3'-O-TBDMS-Ac-rC
5'-O-DMT-3'-O-TBDMS-Ac-rC is a modified nucleoside and can be used to synthesize DNA or RNA.
More description
DC46670 5'-O-DMT-2'-TBDMS-Uridine
5'-O-DMT-2'-TBDMS-Uridine is a deoxyribonucleoside used for the oligonucleotide synthesis.
More description
DC46669 5'-O-DMT-2'-O-TBDMS-Ac-rC
5'-O-DMT-2'-O-TBDMS-Ac-rC is a modified nucleoside and can be used to synthesize DNA or RNA.
More description
DC46668 2'-OMe-G(ibu) Phosphoramidite
2'-OMe-G(ibu) Phosphoramidite is a modified phosphoramidite monomer, which can be used for the oligonucleotide synthesis.
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X